AlphaValue/Baader Europe Upgrades Novartis to Add, Trims PT

08:26 AM EDT, 09/09/2026 (MT Newswires) -- AlphaValue/Baader Europe on Wednesday upgraded Swiss drugmaker Novartis (NOVN.SW) to add from reduce and lowered its price target to 133 francs from 134 francs. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)